2006
DOI: 10.1152/ajprenal.00062.2005
|View full text |Cite
|
Sign up to set email alerts
|

Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate α-ENaC and sgk1 expression in renal collecting duct epithelia

Abstract: Thomas, Christie P., Kang Z. Liu, and Hemender S. Vats. Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate ␣-ENaC and sgk1 expression in renal collecting duct epithelia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(20 citation statements)
references
References 43 publications
0
20
0
Order By: Relevance
“…10 Collective evidence, thus, strongly suggests that synthetic progestins act differently because of different profiles in the activation of, for example, androgen and glucocorticoid receptors, and it seems likely that some progestins increase vascular injury, whereas others exert rather beneficial effects. 11,39,40 The observation that MPA attenuated the protective effect of 17␤-estradiol in AST rats could be explained either by enhanced mineralocorticoid activity or, alternatively, by inhibition of estrogen action. To discriminate between these mechanisms, we analyzed the cardiovascular phenotype of ovx AST rats on long-term administration of MPA.…”
Section: Discussionmentioning
confidence: 99%
“…10 Collective evidence, thus, strongly suggests that synthetic progestins act differently because of different profiles in the activation of, for example, androgen and glucocorticoid receptors, and it seems likely that some progestins increase vascular injury, whereas others exert rather beneficial effects. 11,39,40 The observation that MPA attenuated the protective effect of 17␤-estradiol in AST rats could be explained either by enhanced mineralocorticoid activity or, alternatively, by inhibition of estrogen action. To discriminate between these mechanisms, we analyzed the cardiovascular phenotype of ovx AST rats on long-term administration of MPA.…”
Section: Discussionmentioning
confidence: 99%
“…mIMCD-3 cells were transfected with a control luciferase vector lacking promoter elements (pGL3) or the αENaC luciferase construct containing 1.3 kbp of the mouse αENaC promoter (23). Cells were cotransfected with either empty expression vector (pCMV-Sport6) or a Per1 expression plasmid (24).…”
Section: Figurementioning
confidence: 99%
“…Alternative mechanisms that could explain the further deterioration of LV function in rats treated with MPA plus E2 may have played a role. Importantly, synthetic progestins such as MPA bind and transactivate not only their cognate receptor but also the MR, the AR, and the GR (Sitruk-Ware 2004;Schindler et al 2003;Thomas, Liu, and Vats 2006). Excessive, liganddependent MR activation has repeatedly been shown to impair cardiac remodeling and chronic HF.…”
Section: Discussionmentioning
confidence: 99%